Clinical trials
Recruiting Multiple Sclerosis, Relapsing-Remitting trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 4 |
| 2023 | 7 |
| 2024 | 10 |
| 2025 | 9 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 49 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amsterdam UMC, location VUmc | 2 |
| Georgia State University | 2 |
| Heinrich-Heine University, Duesseldorf | 2 |
| Novartis Pharmaceuticals | 2 |
| Shirley Ryan AbilityLab | 2 |
| University Hospital, Basel, Switzerland | 2 |
| University of California, San Francisco | 2 |
| Biocad | 1 |
| Bristol-Myers Squibb | 1 |
| Cedars-Sinai Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 49 |
| Multiple Sclerosis | 30 |
| Multiple Sclerosis, Chronic Progressive | 12 |
| Fatigue | 3 |
| Autoimmune Diseases of the Nervous System | 2 |
| Cognitive Dysfunction | 2 |
| Hypoxia | 2 |
| Nervous System Diseases | 2 |
| Optic Neuritis | 2 |
| Anxiety Disorders | 1 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.